MARC REITZNER: Open Payments
NPI 1790732162 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,107 in 158 payments from 20 companies in 2025. Trend: 2023 $3,268 · 2024 $5,848 · 2025 $5,107
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 60 | $3,092 |
| Boston Scientific Corporation | 6 | $283 |
| Medtronic, Inc. | 13 | $273 |
| Amgen Inc. | 7 | $243 |
| Novartis Pharmaceuticals Corporation | 18 | $179 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $163 |
| AstraZeneca Pharmaceuticals LP | 9 | $158 |
| Novo Nordisk Inc | 12 | $153 |
| HEARTFLOW, INC. | 7 | $138 |
| Abbott Laboratories | 1 | $110 |
Products named: SAPIEN 3 Ultra RESILIA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), WATCHMAN FLX, COREVALVE EVOLUT R, REPATHA, LifeVest, LEQVIO.
Industry payments across MO — which companies pay providers there.
